ADMA BIOLOGICS INC - COMMON STOCK

ADMA Biologics Announces CFO Transition

28 2 2024 16:10:00 提供 Nasdaq GlobeNewswire

ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

28 2 2024 16:05:00 提供 Nasdaq GlobeNewswire

ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

21 2 2024 16:05:00 提供 Nasdaq GlobeNewswire

ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics

21 2 2024 07:00:00 提供 Nasdaq GlobeNewswire

ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update

08 1 2024 07:00:01 提供 Nasdaq GlobeNewswire

ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management

18 12 2023 16:05:00 提供 Nasdaq GlobeNewswire

ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older

12 12 2023 07:00:00 提供 Nasdaq GlobeNewswire

ADMA BioCenters Receives FDA Approval for its Tenth Plasma Collection Center, Located in Laurel, MD

16 11 2023 07:00:00 提供 Nasdaq GlobeNewswire

ADMA Biologics Announces Third Quarter 2023 Financial Results and Provides Business Update

08 11 2023 16:05:01 提供 Nasdaq GlobeNewswire

ADMA Biologics to Report Third Quarter 2023 Financial Results on November 8, 2023

01 11 2023 07:00:00 提供 Nasdaq GlobeNewswire

ADMA Biologics Announces Second Quarter 2023 Financial Results and Provides Business Update

09 8 2023 16:05:01 提供 Nasdaq GlobeNewswire

ADMA Biologics to Report Second Quarter 2023 Financial Results on August 9, 2023

02 8 2023 07:00:02 提供 Nasdaq GlobeNewswire

ADMA BioCenters Receives FDA Approval for its Ninth Plasma Collection Center, Located in Dallas, GA

19 7 2023 07:00:00 提供 Nasdaq GlobeNewswire

ADMA Biologics Announces First Quarter 2023 Financial Results and Provides Business Update

10 5 2023 16:05:01 提供 Nasdaq GlobeNewswire

ADMA Biologics to Report First Quarter 2023 Financial Results on May 10, 2023

03 5 2023 07:00:01 提供 Nasdaq GlobeNewswire

ADMA Biologics Announces Amendment to Credit Agreement

02 5 2023 07:00:00 提供 Nasdaq GlobeNewswire

ADMA Biologics Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

23 3 2023 16:05:00 提供 Nasdaq GlobeNewswire

ADMA Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023

16 3 2023 07:00:01 提供 Nasdaq GlobeNewswire

ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA

08 2 2023 07:00:00 提供 Nasdaq GlobeNewswire

ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2022 Revenues and Provides 2023 Financial Guidance

17 1 2023 07:00:00 提供 Nasdaq GlobeNewswire